Skip to Main content Skip to Navigation

Planification de traitement en micro-curiethérapie

Abstract : An innovative form of radiotherapy, microbrachytherapy, is under development. This therapy targets solid, inoperable tumours by performing injections of liquid containing radioactive microspheres in suspension. Many injections are required to sufficiently cover the tumoural volume, and so to be able to deliver the position of these injections, a method of treatment planning has been developed and validated throughout this research. Throughout this work, three main questions are addressed: • How to perform the dosimetry for microbrachytherapy? • How to perform treatment planning for this modality? • What are the optimal injection properties to deliver the most efficient treatment? Microbrachytherapy dosimetry was performed by calculating the absorbed dose distribution for an injection. This distribution was then convolved at each injection position within the tumour to calculate the patient's absorbed dose distribution. Dosimetry of the tumour and the organs at risk was performed by extracting and analysing dose-volume histograms (DVHs). Once a method of dosimetry was put in place, optimisation algorithms were developed to generate patient-specific treatment plans. For this, three algorithms were tested and compared: Nelder-Mead Simplex, the Bees algorithm and the non-dominated sorting genetic algorithm II. It was found that, thanks to its MO optimisation, the non-dominated sorting algorithm II was the most flexible, and was used preferentially. Lastly, a comparison of injection parameters was performed. It was found that between 90Y, 166Ho, 131I and 177Lu, optimal injections consisted of microspheres of 90Y. Injection volumes of 5, 10 and 20 µL and initial activities of 5, 10 and 20 MBq were tested. It was found that 20 µL injections with 20 MBq were optimal because they minimise the number of injections required. This new technology combined with developments shown in this work demonstrate the feasibility - that was validated on animals - the ability to inject liquid containing radioactive microspheres in suspension to efficiently treat inoperable tumours whilst protecting surrounding healthy tissue. Such tumours, despite still having a poor prognosis, will surely have better support in the near future.
Document type :
Complete list of metadatas
Contributor : Abes Star :  Contact
Submitted on : Thursday, January 24, 2019 - 11:33:20 AM
Last modification on : Tuesday, March 17, 2020 - 12:26:02 PM
Long-term archiving on: : Thursday, April 25, 2019 - 1:38:42 PM


Version validated by the jury (STAR)


  • HAL Id : tel-01992079, version 1



Richard Brown. Planification de traitement en micro-curiethérapie. Human health and pathology. Université Paul Sabatier - Toulouse III, 2017. English. ⟨NNT : 2017TOU30180⟩. ⟨tel-01992079⟩



Record views


Files downloads